中昌國際控股(00859.HK)獲中國信達提要約收購 6日下午1時復牌
格隆匯4月6日丨中昌國際控股(00859.HK)公佈,於2020年3月24日,公司收到由中國信達(香港)聯席財務顧問信達國際及富域資本發出的通知,內容有關中國信達(香港)將就中國信達(香港)及其一致行動人士已經擁有或已經同意收購的股份以外的全部已發行股份,透過要約人作出強制全面現金要約。
於2020年4月3日,要約人刊發要約公佈,當中表明信達國際將遵照收購守則規定,代表要約人作出將為無條件要約,每股要約股份現金0.5425港元。
此外,公司已向聯交所申請於2020年4月6日下午1時正起恢復股份在聯交所買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.